SEARCH

SEARCH BY CITATION

References

  • Adam D., Wiegmann K., Adam-Klages S., Ruff A. and Kronke M. (1996) A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J. Biol. Chem. 271, 1461714622.
  • Ahmad T. Y., Beaudet A. L., Sparrow J. T. and Morrisett J. D. (1986) Human lysosomal sphingomyelinase: substrate efficacy of apolipoprotein/sphingomyelin complexes. Biochemistry 25, 44154420.
  • Almeida R., Amado M., David L. et al. (1997) A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3. J. Biol. Chem. 272, 3197931991.
  • Anelli V., Bassi R., Tettamanti G., Viani P. and Riboni L. (2005) Extracellular release of newly synthesized sphingosine-1-phosphate by cerebellar granule cells and astrocytes. J. Neurochem. 92, 12041215.
  • Arai T., Bhunia A. K., Chatterjee S. and Bulkley G. B. (1998) Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ. Res. 82, 540547.
  • Ayasolla K., Khan M., Singh A. K. and Singh I. (2004) Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E. Free Radic. Biol. Med. 37, 325338.
  • Bassi R., Anelli V., Giussani P., Tettamanti G., Viani P. and Riboni L. (2006) Sphingosine-1-phosphate is released by cerebellar astrocytes in response to bFGF and induces astrocyte proliferation through Gi-protein-coupled receptors. Glia 53, 621630.
  • Beckman J. S. and Koppenol W. H. (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 271, C1424C1437.
  • Bernardo K., Krut O., Wiegmann K. et al. (2000) Purification and characterization of a magnesium-dependent neutral sphingomyelinase from bovine brain. J. Biol. Chem. 275, 76417647.
  • Bezombes C., De Thonel A., Apostolou A., Louat T., Jaffrezou J. P., Laurent G. and Quillet-Mary A. (2002) Overexpression of protein kinase Czeta confers protection against antileukemic drugs by inhibiting the redox-dependent sphingomyelinase activation. Mol. Pharmacol. 62, 14461455.
  • Bhunia A. K., Han H., Snowden A. and Chatterjee S. (1997) Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J. Biol. Chem. 272, 1564215649.
  • Bhunia A. K., Arai T., Bulkley G. and Chatterjee S. (1998) Lactosylceramide mediates tumor necrosis factor-alpha-induced intercellular adhesion molecule-1 (ICAM-1) expression and the adhesion of neutrophil in human umbilical vein endothelial cells. J. Biol. Chem. 273, 3434934357.
  • Bilderback T. R., Gazula V. R. and Dobrowsky R. T. (2001) Phosphoinositide 3-kinase regulates crosstalk between Trk A tyrosine kinase and p75(NTR)-dependent sphingolipid signaling pathways. J. Neurochem. 76, 15401551.
  • Bokoch G. M. and Diebold B. A. (2002) Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood 100, 26922696.
  • Bolli R., Dawn B. and Xuan Y. T. (2001) Emerging role of the JAK-STAT pathway as a mechanism of protection against ischemia/reperfusion injury. J. Mol. Cell. Cardiol. 33, 18931896.
  • Brown D. A. and London E. (2000) Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275, 1722117224.
  • Chalfant C. E. and Spiegel S. (2005) Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling. J. Cell Sci. 118, 46054612.
  • Chatterjee S. (1998) Sphingolipids in atherosclerosis and vascular biology. Arterioscler. Thromb. Vasc. Biol. 18, 15231533.
  • Chatterjee S., Ghosh N. and Khurana S. (1992) Purification of uridine diphosphate-galactose:glucosyl ceramide, beta 1-4 galactosyltransferase from human kidney. J. Biol. Chem. 267, 71487153.
  • Contreras F. X., Basanez G., Alonso A., Herrmann A. and Goni F. M. (2005) Asymmetric addition of ceramides but not dihydroceramides promotes transbilayer (flip-flop) lipid motion in membranes. Biophys. J. 88, 348359.
  • Cremesti A. E., Goni F. M. and Kolesnick R. (2002) Role of sphingomyelinase and ceramide in modulating rafts: do biophysical properties determine biologic outcome? FEBS Lett. 531, 4753.
  • Dawson V. L. and Dawson T. M. (1998) Nitric oxide in neurodegeneration. Prog. Brain Res. 118, 215229.
  • De Rosa M. F., Sillence D., Ackerley C. and Lingwood C. (2004) Role of multiple drug resistance protein 1 in neutral but not acidic glycosphingolipid biosynthesis. J. Biol. Chem. 279, 78677876.
  • Dobrowsky R. T., Kamibayashi C., Mumby M. C. and Hannun Y. A. (1993) Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268, 1552315530.
  • Ebadi M. and Sharma S. K. (2003) Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson’s disease. Antioxid. Redox Signal. 5, 319335.
  • Eckford P. D. and Sharom F. J. (2005) The reconstituted P-glycoprotein multidrug transporter is a flippase for glucosylceramide and other simple glycosphingolipids. Biochem. J. 389, 517526.
  • El-Assaad W., El-Sabban M., Awaraji C., Abboushi N. and Dbaibo G. S. (1998) Distinct sites of action of Bcl-2 and Bcl-xL in the ceramide pathway of apoptosis. Biochem. J. 336 (Pt 3), 735741.
  • Futerman A. H. (2006) Intracellular trafficking of sphingolipids: relationship to biosynthesis. Biochim. Biophys. Acta 1758, 18851892.
  • Futerman A. H. and Riezman H. (2005) The ins and outs of sphingolipid synthesis. Trends Cell Biol. 15, 312318.
  • Garcia-Ruiz C., Colell A., Paris R. and Fernandez-Checa J. C. (2000) Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation. FASEB J. 14, 847858.
  • Gomez-Munoz A., Kong J., Salh B. and Steinbrecher U. P. (2003) Sphingosine-1-phosphate inhibits acid sphingomyelinase and blocks apoptosis in macrophages. FEBS Lett. 539, 5660.
  • Grassme H., Jekle A., Riehle A., Schwarz H., Berger J., Sandhoff K., Kolesnick R. and Gulbins E. (2001) CD95 signaling via ceramide-rich membrane rafts. J. Biol. Chem. 276, 2058920596.
  • Grassme H., Bock J., Kun J. and Gulbins E. (2002a) Clustering of CD40 ligand is required to form a functional contact with CD40. J. Biol. Chem. 277, 3028930299.
  • Grassme H., Jendrossek V., Bock J., Riehle A. and Gulbins E. (2002b) Ceramide-rich membrane rafts mediate CD40 clustering. J. Immunol. 168, 298307.
  • Grazide S., Maestre N., Veldman R. J., Bezombes C., Maddens S., Levade T., Laurent G. and Jaffrezou J. P. (2002) Ara-C- and daunorubicin-induced recruitment of Lyn in sphingomyelinase-enriched membrane rafts. FASEB J. 16, 16851687.
  • Guillas I., Kirchman P. A., Chuard R., Pfefferli M., Jiang J. C., Jazwinski S. M. and Conzelmann A. (2001) C26-CoA-dependent ceramide synthesis of Saccharomyces cerevisiae is operated by Lag1p and Lac1p. EMBO J. 20, 26552665.
  • Gulbins E. and Grassme H. (2002) Ceramide and cell death receptor clustering. Biochim. Biophys. Acta 1585, 139145.
  • Hakomori Si S. I. (2002) Inaugural Article: The glycosynapse. Proc. Natl Acad. Sci. USA 99, 225232.
  • Han X., Holltzman D. M., McKeel D. W., Jr., Kelley J. and Morris J. C. (2002) Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer’s disease: potential role in disease pathogenesis. J. Neurochem. 82, 809818.
  • Hanada K., Kumagai K., Yasuda S., Miura Y., Kawano M., Fukasawa M. and Nishijima M. (2003) Molecular machinery for non-vesicular trafficking of ceramide. Nature 426, 803809.
  • Hanissian S. H. and Geha R. S. (1997) Jak3 is associated with CD40 and is critical for CD40 induction of gene expression in B cells. Immunity 6, 379387.
  • Hickey M. J., Granger D. N. and Kubes P. (2001) Inducible nitric oxide synthase (iNOS) and regulation of leucocyte/endothelial cell interactions: studies in iNOS-deficient mice. Acta Physiol. Scand. 173, 119126.
  • Hofmann K., Tomiuk S., Wolff G. and Stoffel W. (2000) Cloning and characterization of the mammalian brain-specific, Mg2+-dependent neutral sphingomyelinase. Proc. Natl Acad. Sci. USA 97, 58955900.
  • Holopainen J. M., Subramanian M. and Kinnunen P. K. (1998) Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane. Biochemistry 37, 1756217570.
  • Horinouchi K., Erlich S., Perl D. P., Ferlinz K., Bisgaier C. L., Sandhoff K., Desnick R. J., Stewart C. L. and Schuchman E. H. (1995) Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease. Nat. Genet. 10, 288293.
  • Hurwitz R., Ferlinz K., Vielhaber G., Moczall H. and Sandhoff K. (1994) Processing of human acid sphingomyelinase in normal and I-cell fibroblasts. J. Biol. Chem. 269, 54405445.
  • Ichikawa S. and Hirabayashi Y. (1998) Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 8, 198202.
  • Ichikawa S., Sakiyama H., Suzuki G., Hidari K. I. and Hirabayashi Y. (1996) Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl Acad. Sci. USA 93, 46384643.
  • Itoh N. and Nagata S. (1993) A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen. J. Biol. Chem. 268, 1093210937.
  • Iwabuchi K. and Nagaoka I. (2002) Lactosylceramide-enriched glycosphingolipid signaling domain mediates superoxide generation from human neutrophils. Blood 100, 14541464.
  • Jaffrey S. R. and Snyder S. H. (1995) Nitric oxide: a neural messenger. Annu. Rev. Cell Dev. Biol. 11, 417440.
  • Janssen-Heininger Y. M., Macara I. and Mossman B. T. (1999) Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am. J. Respir. Cell Mol. Biol. 20, 942952.
  • Jeyakumar M., Thomas R., Elliot-Smith E., Smith D. A., Van Der Spoel A. C., D’Azzo A., Perry V. H., Butters T. D., Dwek R. A. and Platt F. M. (2003) Central nervous system inflammation is a hallmark of pathogenesis in mouse models of GM1 and GM2 gangliosidosis. Brain 126, 974987.
  • Kannagi R., Izawa M., Koike T., Miyazaki K. and Kimura N. (2004) Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis. Cancer Sci. 95, 377384.
  • Kawamata T., Speliotes E. K. and Finklestein S. P. (1997) The role of polypeptide growth factors in recovery from stroke. Adv. Neurol. 73, 377382.
  • Kiemer A. K. and Vollmar A. M. (1998) Autocrine regulation of inducible nitric-oxide synthase in macrophages by atrial natriuretic peptide. J. Biol. Chem. 273, 1344413451.
  • Kimura A., Ohmori T., Ohkawa R., Madoiwa S., Mimuro J., Murakami T., Kobayashi E., Hoshino Y., Yatomi Y. and Sakata Y. (2007) Essential roles of sphingosine 1-phosphate/S1P1 receptor axis in the migration of neural stem cells toward a site of spinal cord injury. Stem Cells 25, 115124.
  • Kleinert H., Wallerath T., Fritz G., Ihrig-Biedert I., Rodriguez-Pascual F., Geller D. A. and Forstermann U. (1998) Cytokine induction of NO synthase II in human DLD-1 cells: roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways. Br. J. Pharmacol. 125, 193201.
  • Kolesnick R. N. (1987) 1,2-Diacylglycerols but not phorbol esters stimulate sphingomyelin hydrolysis in GH3 pituitary cells. J. Biol. Chem. 262, 1675916762.
  • Kolmakova A. and Chatterjee S. (2005) Platelet derived growth factor recruits lactosylceramide to induce cell proliferation in UDP Gal:GlcCer: beta1 –> 4Galactosyltransferase (GalT-V) mutant Chinese hamster ovary cells. Glycoconj. J. 22, 401407.
  • Kondo T., Kitano T., Iwai K., Watanabe M., Taguchi Y., Yabu T., Umehara H., Domae N., Uchiyama T. and Okazaki T. (2002) Control of ceramide-induced apoptosis by IGF-1: involvement of PI-3 kinase, caspase-3 and catalase. Cell Death Differ. 9, 682692.
  • Koyanagi S., Kuga M., Soeda S., Hosoda Y., Yokomatsu T., Takechi H., Akiyama T., Shibuya S. and Shimeno H. (2003) Elevation of de novo ceramide synthesis in tumor masses and the role of microsomal dihydroceramide synthase. Int. J. Cancer 105, 16.
  • Koybasi S., Senkal C. E., Sundararaj K. et al. (2004) Defects in cell growth regulation by C18:0-ceramide and longevity assurance gene 1 in human head and neck squamous cell carcinomas. J. Biol. Chem. 279, 4431144319.
  • Kreder D., Krut O., Adam-Klages S. et al. (1999) Impaired neutral sphingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J. 18, 24722479.
  • Kumagai K., Yasuda S., Okemoto K., Nishijima M., Kobayashi S. and Hanada K. (2005) CERT mediates intermembrane transfer of various molecular species of ceramides. J. Biol. Chem. 280, 64886495.
  • Kunz D., Walker G., Eberhardt W. and Pfeilschifter J. (1996) Molecular mechanisms of dexamethasone inhibition of nitric oxide synthase expression in interleukin 1 beta-stimulated mesangial cells: evidence for the involvement of transcriptional and posttranscriptional regulation. Proc. Natl Acad. Sci. USA 93, 255259.
  • Lambeth J. D. (2002) Nox/Duox family of nicotinamide adenine dinucleotide (phosphate) oxidases. Curr. Opin. Hematol. 9, 1117.
  • Lamour N. F. and Chalfant C. E. (2005) Ceramide-1-phosphate: the “missing” link in eicosanoid biosynthesis and inflammation. Mol. Interv. 5, 358367.
  • Lannert H., Gorgas K., Meissner I., Wieland F. T. and Jeckel D. (1998) Functional organization of the Golgi apparatus in glycosphingolipid biosynthesis. Lactosylceramide and subsequent glycosphingolipids are formed in the lumen of the late Golgi. J. Biol. Chem. 273, 29392946.
  • Lavie Y., Cao H., Bursten S. L., Giuliano A. E. and Cabot M. C. (1996) Accumulation of glucosylceramides in multidrug-resistant cancer cells. J. Biol. Chem. 271, 1953019536.
  • Lee J. T., Xu J., Lee J. M., Ku G., Han X., Yang D. I., Chen S. and Hsu C. Y. (2004) Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway. J. Cell Biol. 164, 123131.
  • Liu B. and Hannun Y. A. (1997) Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione. J. Biol. Chem. 272, 1628116287.
  • Lo N. W., Shaper J. H., Pevsner J. and Shaper N. L. (1998) The expanding beta 4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8, 517526.
  • Lucci A., Cho W. I., Han T. Y., Giuliano A. E., Morton D. L. and Cabot M. C. (1998) Glucosylceramide: a marker for multiple-drug resistant cancers. Anticancer Res. 18, 475480.
  • Marchesini N. and Hannun Y. A. (2004) Acid and neutral sphingomyelinases: roles and mechanisms of regulation. Biochem. Cell Biol. 82, 2744.
  • Marchesini N., Luberto C. and Hannun Y. A. (2003) Biochemical properties of mammalian neutral sphingomyelinase 2 and its role in sphingolipid metabolism. J. Biol. Chem. 278, 1377513783.
  • Marks D. L. and Pagano R. E. (2002) Endocytosis and sorting of glycosphingolipids in sphingolipid storage disease. Trends Cell Biol. 12, 605613.
  • Martin S. F., Williams N. and Chatterjee S. (2006) Lactosylceramide is required in apoptosis induced by N-Smase. Glycoconj. J. 23, 147157.
  • Mathias S., Dressler K. A. and Kolesnick R. N. (1991) Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc. Natl Acad. Sci. USA 88, 1000910013.
  • Mizutani Y., Kihara A. and Igarashi Y. (2005) Mammalian Lass6 and its related family members regulate synthesis of specific ceramides. Biochem. J. 390, 263271.
  • Moskwa P., Palicz A., Paclet M. H., Dagher M. C., Erdos M., Marodi L. and Ligeti E. (2004) Glucocerebroside inhibits NADPH oxidase activation in cell-free system. Biochim. Biophys. Acta 1688, 197203.
  • Muller G., Ayoub M., Storz P., Rennecke J., Fabbro D. and Pfizenmaier K. (1995) PKC zeta is a molecular switch in signal transduction of TNF-alpha, bifunctionally regulated by ceramide and arachidonic acid. EMBO J. 14, 19611969.
  • Narimatsu H., Sinha S., Brew K., Okayama H. and Qasba P. K. (1986) Cloning and sequencing of cDNA of bovine N-acetylglucosamine (beta 1-4)galactosyltransferase. Proc. Natl Acad. Sci. USA 83, 47204724.
  • Nathan C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J. 6, 30513064.
  • Nauseef W. M. (2004) Assembly of the phagocyte NADPH oxidase. Histochem. Cell Biol. 122, 277291.
  • Norenberg M. D. (1994) Astrocyte responses to CNS injury. J. Neuropathol. Exp. Neurol. 53, 213220.
  • Okamoto Y., Obeid L. M. and Hannun Y. A. (2002) Bcl-xL interrupts oxidative activation of neutral sphingomyelinase. FEBS Lett. 530, 104108.
  • Pahan K., Sheikh F. G., Khan M., Namboodiri A. M. and Singh I. (1998) Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes. J. Biol. Chem. 273, 25912600.
  • Pannu R., Won J. S., Khan M., Singh A. K. and Singh I. (2004) A novel role of lactosylceramide in the regulation of lipopolysaccharide/interferon-gamma-mediated inducible nitric oxide synthase gene expression: implications for neuroinflammatory diseases. J. Neurosci. 24, 59425954.
  • Pannu R., Singh A. K. and Singh I. (2005) A novel role of lactosylceramide in the regulation of tumor necrosis factor alpha-mediated proliferation of rat primary astrocytes. Implications for astrogliosis following neurotrauma. J. Biol. Chem. 280, 1374213751.
  • Paul P., Kamisaka Y., Marks D. L. and Pagano R. E. (1996) Purification and characterization of UDP-glucose:ceramide glucosyltransferase from rat liver Golgi membranes. J. Biol. Chem. 271, 22872293.
  • Perry R. J. and Ridgway N. D. (2005) Molecular mechanisms and regulation of ceramide transport. Biochim. Biophys. Acta 1734, 220234.
  • Pushkareva M., Obeid L. M. and Hannun Y. A. (1995) Ceramide: an endogenous regulator of apoptosis and growth suppression. Immunol. Today 16, 294297.
  • Quintern L. E. and Sandhoff K. (1991) Human acid sphingomyelinase from human urine. Methods Enzymol. 197, 536540.
  • Rajesh M., Kolmakova A. and Chatterjee S. (2005) Novel role of lactosylceramide in vascular endothelial growth factor-mediated angiogenesis in human endothelial cells. Circ. Res. 97, 796804.
  • Reinehr R., Becker S., Eberle A., Grether-Beck S. and Haussinger D. (2005) Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280, 2717927194.
  • Riezman H. and Van Meer G. (2004) Lipid pickup and delivery. Nat. Cell Biol. 6, 1516.
  • Rosen H. and Goetzl E. J. (2005) Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network. Nature reviews 5, 560570.
  • Sato T., Furukawa K., Bakker H., Van den Eijnden D. H. and Van Die I. (1998) Molecular cloning of a human cDNA encoding beta-1,4-galactosyltransferase with 37% identity to mammalian UDP-Gal:GlcNAc beta-1,4-galactosyltransferase. Proc. Natl Acad. Sci. USA 95, 472477.
  • Sawai H., Domae N., Nagan N. and Hannun Y. A. (1999) Function of the cloned putative neutral sphingomyelinase as lyso-platelet activating factor-phospholipase C. J. Biol. Chem. 274, 3813138139.
  • Schissel S. L., Schuchman E. H., Williams K. J. and Tabas I. (1996) Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J. Biol. Chem. 271, 1843118436.
  • Schneider P. B. and Kennedy E. P. (1967) Sphingomyelinase in normal human spleens and in spleens from subjects with Niemann-Pick disease. J. Lipid Res. 8, 202209.
  • Schorling S., Vallee B., Barz W. P., Riezman H. and Oesterhelt D. (2001) Lag1p and Lac1p are essential for the Acyl-CoA-dependent ceramide synthase reaction in Saccharomyces cerevisae. Mol. Biol. Cell 12, 34173427.
  • Schulz A., Mousallem T., Venkataramani M. et al. (2006) The CLN9 protein, a regulator of dihydroceramide synthase. J. Biol. Chem. 281, 27842794.
  • Schwientek T., Almeida R., Levery S. B., Holmes E. H., Bennett E. and Clausen H. (1998) Cloning of a novel member of the UDP-galactose:beta-N-acetylglucosamine beta1,4-galactosyltransferase family, beta4Gal-T4, involved in glycosphingolipid biosynthesis. J. Biol. Chem. 273, 2933129340.
  • Segui B., Andrieu-Abadie N., Adam-Klages S. et al. (1999) CD40 signals apoptosis through FAN-regulated activation of the sphingomyelin-ceramide pathway. J. Biol. Chem. 274, 3725137258.
  • Shaper N. L., Shaper J. H., Meuth J. L., Fox J. L., Chang H., Kirsch I. R. and Hollis G. F. (1986) Bovine galactosyltransferase: identification of a clone by direct immunological screening of a cDNA expression library. Proc. Natl Acad. Sci. USA 83, 15731577.
  • Simons K. and Toomre D. (2000) Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1, 3139.
  • Singh I., Pahan K., Khan M. and Singh A. K. (1998) Cytokine-mediated induction of ceramide production is redox-sensitive. Implications to proinflammatory cytokine-mediated apoptosis in demyelinating diseases. J. Biol. Chem. 273, 2035420362.
  • Sumitomo M., Ohba M., Asakuma J., Asano T., Kuroki T., Asano T. and Hayakawa M. (2002) Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J. Clin. Invest. 109, 827836.
  • Taha T. A., Hannun Y. A. and Obeid L. M. (2006) Sphingosine kinase: biochemical and cellular regulation and role in disease. J. Biochem. Mol. Biol. 39, 113131.
  • Takahashi J. A., Fukumoto M., Igarashi K., Oda Y., Kikuchi H. and Hatanaka M. (1992) Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J. Neurosurg. 76, 792798.
  • Takeda Y., Tashima M., Takahashi A., Uchiyama T. and Okazaki T. (1999) Ceramide generation in nitric oxide-induced apoptosis. Activation of magnesium-dependent neutral sphingomyelinase via caspase-3. J. Biol. Chem. 274, 1065410660.
  • Tani M., Ito M. and Igarashi Y. (2007) Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space. Cell. Signal. 19, 229237.
  • Tas P. W. and Koschel K. (1998) Sphingosine-1-phosphate induces a Ca2+ signal in primary rat astrocytes and a Ca2+ signal and shape changes in C6 rat glioma cells. J. Neurosci. Res. 52, 427434.
  • Tomiuk S., Hofmann K., Nix M., Zumbansen M. and Stoffel W. (1998) Cloned mammalian neutral sphingomyelinase: functions in sphingolipid signaling? Proc. Natl Acad. Sci. USA 95, 36383643.
  • Veiga M. P., Arrondo J. L., Goni F. M. and Alonso A. (1999) Ceramides in phospholipid membranes: effects on bilayer stability and transition to nonlamellar phases. Biophys. J. 76, 342350.
  • Venkataraman K. and Futerman A. H. (2000) Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol. 10, 408412.
  • Wink D. A., Kasprzak K. S., Maragos C. M. et al. (1991) DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science 254, 10011003.
  • Won J. S. and Singh I. (2006) Sphingolipid signaling and redox regulation. Free Radic. Biol. Med. 40, 18751888.
  • Won J. S., Im Y. B., Singh A. K. and Singh I. (2004a) Dual role of cAMP in iNOS expression in glial cells and macrophages is mediated by differential regulation of p38-MAPK/ATF-2 activation and iNOS stability. Free Radic. Biol. Med. 37, 18341844.
  • Won J. S., Im Y. B., Khan M., Singh A. K. and Singh I. (2004b) The role of neutral sphingomyelinase produced ceramide in lipopolysaccharide-mediated expression of inducible nitric oxide synthase. J. Neurochem. 88, 583593.
  • Yoshimura S., Banno Y., Nakashima S., Hayashi K., Yamakawa H., Sawada M., Sakai N. and Nozawa Y. (1999) Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death. J. Neurochem. 73, 675683.
  • Zhang A. Y., Teggatz E. G., Zou A. P., Campbell W. B. and Li P. L. (2005) Endostatin uncouples NO and Ca2+ response to bradykinin through enhanced O2*- production in the intact coronary endothelium. Am. J. Physiol. 288, H686H694.